Cofoe Medical Enters Brain-Computer Interface Field with Two Strategic Investments

Gelonghui January 6thCofoe(301087.SZ)Publish,Currently, Cofoe Medical Technology Co., Ltd. has participated in two strategic investments in the brain-computer interface field. In May 2024, the company invested in Neulink, holding a 5.83% stake. Neulink focuses on implantable brain-computer interface technology, primarily developing bionic eye and bionic ear products. This investment strategically synergizes with the company’s existing hearing business, particularly in addressing congenital hearing loss. By the end of 2025, the company invested in Lizhi Intelligence, holding a 12.45% stake. Lizhi Intelligence is dedicated to non-invasive brain-computer interface technology.RobotThe development of these products is expected to achieve strategic synergy with the company's rehabilitation aids and respiratory support products in the future. Through the above layout, Cofoe Medical Technology Co., Ltd. has strategically entered the brain-computer interface field, not only strengthening the synergy potential of existing businesses but also laying the foundation for future technology integration and industrial upgrading.